Cerebrospinal fluid

Journal of Emergency Medicine

Volumn 21, Issue 2, 2001, Pages 171-178

  Jerrard, David A ^a,b   Hanna, Jeahan R ^a   Schindelheim, Gina L ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Assays; Cerebrospinal fluid; Cost; Indications; Limitations

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; IMMUNOGLOBULIN; TRANSFERRIN;

ACTIVE IMMUNIZATION; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL INFECTION; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID CULTURE; COUNTER IMMUNOELECTROPHORESIS; DIAGNOSTIC PROCEDURE; GLUCOSE BLOOD LEVEL; HUMAN; LATEX AGGLUTINATION TEST; LEUKOCYTE COUNT; MENINGITIS; MICROBIOLOGICAL EXAMINATION; MYCOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; STAINING; TERMINAL DISEASE; TUBERCULOUS MENINGITIS; VIRUS INFECTION;

BACTERIAL INFECTIONS; CEREBROSPINAL FLUID; EMERGENCY MEDICINE; GLUCOSE; HUMANS; LABORATORIES, HOSPITAL; MYCOSES; POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 0034910944     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-4679(01)00360-2     Document Type: Article

References (93)

1. Diagnosis and management of meningitis
2. Cerebrospinal fluid
3. Cerebrospinal fluid as a diagnostic body fluid
4. CSF evaluation in neonates: Comparison of high risk infants with and without meningitis
5. Normal cerebrospinal fluid values in children: Another look
6. Recent survey of infectious meningitis in adults
7. Acute bacterial meningitis
8. Value of second lumbar puncture in confirming the diagnosis of aseptic meningitis
9. Cryptococcal infection of the central nervous system
10. Tuberculous meningitis: Clinical characteristics and comparison with cryptococcal meningitis in patients with human immunodeficiency virus infection
11. The cytology of normal cerebrospinal fluid
12. Drug-induced meningitis: A case involving trimethoprim-sulfamethoxazole
13. Trimetroprim-sulfamethoxazole associated aseptic meningitis
14. Positive culture from normal CSF of Streptococcus pneumoniae meningitis
15. Haemophilus influenzae meningitis in an adult with initially normal cerebrospinal fluid
16. Meningococcal meningitis with "normal cerebrospinal fluid"
17. Tuberculous meningitis in patients infected with the human immunodeficiency virus
18. Tuberculous meningitis in patients with and without human immunodeficiency virus infection
19. Tuberculous meningitis with acellular cerebrospinal fluid in AIDS patients
20. Tuberculous meningitis: A 30 year review
21. Meningitis. Clinical presentation and work-up
22. Cerebrospinal fluid glucose and leucocyte responses in experimental meningitis
23. The rapid differential diagnosis of meningitis
24. Persistent hypoglycorrhachia in neurobrucellosis
25. Cerebrospinal fluid
26. Acute bacterial meningitis
27. Pneumococcal meningitis with normal cerebrospinal fluid in an immunocompetent adult
28. The aseptic meningitis syndrome
29. Comparisons of cryptococcal and tuberculous meningitis
30. Clinical significance of Candida species isolated from cerebrospinal fluid following neurosurgery
31. Cerebrospinal fluid data: Interpretation in intracranial hemorrhage and meningitis
32. Evaluating body fluids
33. Antibody persistence and Haemophilus influenzae type b carriage after infant immunisation with PRP-T
34. Ten years experience with Haemophilus influenzae type b (Hib) conjugate vaccines in Finland
35. Serum antibiotics in 6 year old children vaccinated in infancy with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine
36. Impact of immunization on Haemophilus influenzae type b disease
37. Quantitation of bacteria in cerebrospinal fluid and blood in children with meningitis and its diagnostic significance
38. Reassessment of microbiology protocol for cerebrospinal fluid specimens
39. Microscopic examination and broth culture of cerebrospinal fluid in diagnosis of meningitis
40. Clinical laboratory analysis of cytospin-prepared Gram stains for recovery and diagnosis of bacteria from sterile body fluids
41. Acute meningitis with a negative Gram's stain: Clinical and management outcomes in 171 episodes
42. Post-neurosurgical and spontaneous Gram-negative bacillary meningitis in adults
43. Acute bacterial meningitis in adults: A 20 year overview
44. Three-year multicenter surveillance of pneumococcal meningitis in children: Clinical characteristics and outcome related to penicillin susceptibility and dexamethasone use
45. Pneumococcal meningitis: Late neurological sequence and features of prognostic impact
46. Clinical utility of broth cultures of cerebrospinal fluid from patients at risk for shunt infections
47. Cerebrospinal fluid broth culture isolates: Their significance for antibiotic treatment
48. Bacterial meningitis in infants and children
49. The cerebrospinal fluid: Physiologic aspects and alterations associated with bacterial meningitis
50. Antigen detection in cerebrospinal fluid: Pros and cons
51. Latex particle agglutination test in the diagnosis of Haemophilus influenzae type b, Streptococcus pneumoniae and Neisseria meningitidis A and C meningitis in infants and children
52. Rapid disappearance of Haemophilus type b meningitis after routine childhood immunization with conjugate vaccines
53. Rapid bacterial antigen detection is not clinically useful
54. Protective efficacy of a serotype B meningococcal vaccine in Sao Paolo, Brazil
55. False-positive latex agglutination result in cerebrospinal fluid after immunization for Haemophilus influenzae type b
56. CSF bacterial antigen detection tests offer no advantage over Gram's stain in the diagnosis of bacterial meningitis
57. Clinical usefulness of cerebrospinal fluid bacterial antigen studies
58. The role of bacterial antigen detection tests in the diagnosis of bacterial meningitis
59. The effects of non-classic pediatric bacterial pathogens on the usefulness of the directigen Latex agglutination test
60. Rapid diagnosis of meningococcal meningitis by polymerase chain reaction
61. Polymerase chain reaction for diagnosis of meningococcal meningitis
62. Detection of bacterial DNA in cerebrospinal fluid by an assay for simultaneous detection of Neisseria meningitis, Haemophilus influenzae, and streptococci using a seminested PCR strategy
63. Diagnosis of meningococcal meningitis by broad range bacterial PCR with cerebrospinal fluid
64. The mortality and pathology of HIV infection in a West African city
65. Tuberculous meningitis: Clinical characteristics and comparison with cryptococcal meningitis in patients with human immunodeficiency virus infection
66. Tuberculous meningitis in patients infected with the human immunodeficiency virus
67. Global epidemiology of tuberculous: Morbidity and mortality of a worldwide epidemic
68. Computed tomography of intracranial tuberculosis
69. Tuberculous meningitis
70. Pediatric tuberculous: An update
71. Polymerase chain reaction in the diagnosis of tuberculous meningitis
72. Rapid diagnosis of tuberculous meningitis by a simplified nested amplification protocol
73. Clinical evaluation of the Gen-Probe amplified direct test for detection of Mycobacterium tuberculous complex organisms in cerebrospinal fluid
74. Diagnostic performance of amplified Mycobacterium tuberculous direct test with cerebrospinal fluid, other non-respiratory and respiratory specimens
75. Detection of fungi in cerebrospinal fluid
76. Cryptococcal meningitis and AIDS
77. Comparisons of cryptococcal and tuberculous meningitis
78. The wide spectrum of cryptococcal infections
79. Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis
80. Diagnostic value of cerebrospinal fluid cytology in comparison with tumor marker activity in central nervous system metastases secondary to breast cancer
81. A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis
82. PCR-detection of tumor-derived p53 DNA in cerebrospinal fluid
83. Immunophenotypin g of cytologic specimens by flow cytometry
84. Cerebrospinal fluid (CSF) cytology: Current status and diagnostic applications
85. Cerebrospinal fluid cytology in patients with cancer: Minimizing false-negative results
86. Toward optimal use of the cytology laboratory: Quality improvement and cerebrospinal fluid specimens
87. Laboratory processing of cerebrospinal fluid specimens
88. Meningeal carcinomatosis in breast cancer: Prognostic factors and influence of treatment
89. Comparison of cisternal and lumbar CSF examination in leptomeningeal metastasis
90. Diagnosis and treatment of patients with meningeal carcinomatosis
91. Meningeal carcinomatosis in patients with breast carcinoma: Clinical features, prognostic factors, and results of a high dose intrathecal methotrexate regimen
92. Carcinomatosis meningitis in patients with breast cancer: An aggressive disease variant
93. The value of multiple fluid specimens in the cytological diagnosis of malignancy